Loading presentation...

Present Remotely

Send the link below via email or IM


Present to your audience

Start remote presentation

  • Invited audience members will follow you as you navigate and present
  • People invited to a presentation do not need a Prezi account
  • This link expires 10 minutes after you close the presentation
  • A maximum of 30 users can follow your presentation
  • Learn more about this feature in our knowledge base article

Do you really want to delete this prezi?

Neither you, nor the coeditors you shared it with will be able to recover it again.


Make your likes visible on Facebook?

Connect your Facebook account to Prezi and let your likes appear on your timeline.
You can change this under Settings & Account at any time.

No, thanks

High-purity, High-efficiency, Label-free Segregation and Rec

No description

Zhewen Tang

on 1 June 2015

Comments (0)

Please log in to add your comment.

Report abuse

Transcript of High-purity, High-efficiency, Label-free Segregation and Rec

High-purity, High-efficiency, Label-free Segregation and Recovery of Circulating Tumor Cells From the Peripheral Blood of Cancer Patients
CTC Chip
1. Circulating Tumor Cells (CTCs)
2. CTC Segregation System
3. Lab and Clinical Results
4. Conclusion and Prospect
1.2 Benchmark Products
Veridex CellSearch
Clearbridge ClearCell
Tang Zhewen, Lv Peitao, Chen Shuiyu, Sun Yukun, Liang Xingjie, Guo Mingzhou, Ray P.S. Han

1.1 Circulating Tumor Cells (CTCs)
Patrizia Paterlini-Brechot, Naoual Linda Benali Cancer Letters 2007, 253, 180-204. Circulating tumor cells (CTC) detection: clinical impact and future directions.
3.1 Chip Characterization
Sample: HeLa cells in PBS
Hela and WBCs. scale bar: 10um
Sample: Healthy Donor Blood + RFP-HeLa - RBCs
Peitao Lv, Zhewen Tang, Xingjie Liang, Mingzhou Guo, and Ray P.S. Han, "Spatially gradated segregation and recovery of circulating tumor cells from peripheral blood of cancer patients",
2013, 7, 034109: http://dx.doi.org/10.1063/1.4808456
lysed blood
normal blood
4. Conclusion and Prospect
~90% Purity & >90% Efficiency
Intact Viable CTCs

Cancer Metastasis Evaluation
Personalized Medicine
Cancer Screening
3.2 Clinical Test Results
3.2 Enumeration Results
Viability of Cells
3.1 Chip Characterization
Blood Clotting Prevention
CTC Segregation System Comparison
CTCs Captured
2. CTC Segregation System
Full transcript